0001050007-17-000019.txt : 20170519 0001050007-17-000019.hdr.sgml : 20170519 20170419133328 ACCESSION NUMBER: 0001050007-17-000019 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP CENTRAL INDEX KEY: 0001050007 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870515089 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: 4356556000 MAIL ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 CORRESP 1 filename1.htm Document
    

NUTRACEUTICAL INTERNATIONAL CORPORATION
1400 Kearns Boulevard, 2nd Floor
Park City, Utah

April 19, 2017
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:     Nutraceutical International Corporation
Registration Statement on Form S-3
(File No. 333-216501)
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Nutraceutical International Corporation, a Delaware corporation (the “Registrant”), hereby requests that the effective date of the above-captioned Registration Statement on Form S-3 (the “Registration Statement”) be accelerated to April 21, 2017 at 2:00 p.m. Eastern time or as soon thereafter as may be practicable.
We understand that the Staff will consider this request as confirmation by the Registrant of its awareness of its responsibilities under the federal securities laws of the United States as they relate to the issuance of the securities covered by the Registration Statement. If you have any questions regarding the foregoing, please contact David Huntington of Paul, Weiss, Rifkind, Wharton & Garrison LLP at (212) 373-3124.
Sincerely,
Nutraceutical International Corporation

By: /s/ Stanley E. Soper    
Name: Stanley E. Soper
Title: Vice President, Legal Affairs

cc:
David Huntington, Esq.
Paul, Weiss, Rifkind, Wharton & Garrison LLP